Ausbiz Capital is now SureStone Capital. Same team, same ABN and AFS authorisations.

ASX Announcements / CSL Limited (ASX:CSL)

All CSL Limited (ASX:CSL) announcement summaries, newest first. Every summary is drawn only from the company's official ASX release.

October 2026

CSL Limited (ASX:CSL)
OperationsPrice Sensitive

CSL to Defend Class Action Over Disclosure Allegations

CSL says a group proceeding filed in the Supreme Court of Victoria alleges continuous disclosure breaches, and that it denies any liability and will defend it.

CSL Limited (ASX:CSL)

9:04 am

22 Oct 2026

CSL Limited (ASX:CSL)
OperationsPrice Sensitive

CSL Pays US$355m Upfront in Alentis Lixudebart Deal

CSL agrees with Alentis to co-develop and co-promote lixudebart, paying US$355 million upfront and funding Phase 2/3 work, with up to US$1.2 billion in further.

CSL Limited (ASX:CSL)

8:22 am

5 Oct 2026

August 2026

CSL Limited (ASX:CSL)
OperationsPrice Sensitive

CSL Posts US$2.6bn Shareholder Loss on US$7.1bn Impairments

CSL reported a US$2.6bn FY26 net loss attributable to shareholders after US$7.1bn of pre-tax impairments, with underlying NPATA attributable of US$3.1bn.

CSL Limited (ASX:CSL)

8:00 am

18 Aug 2026

July 2026

CSL Limited (ASX:CSL)
ClinicalPrice Sensitive

CSL to Trial Enhanced Horizon 2 Plasma Manufacturing

CSL will trial immunoglobulin made with its yield-enhancing Horizon 2 process, with clinical activities to begin in mid-2027 after FDA and EMA engagement.

CSL Limited (ASX:CSL)

9:21 am

29 Jul 2026

Copyright © 2026 SureStone Capital